From muscle wasting to sarcopenia and myopenia: Update 2012

Journal of Cachexia, Sarcopenia and Muscle

Volumn 3, Issue 4, 2012, Pages 213-217

  von Haehling, Stephan ^a   Morley, John E ^b   Anker, Stefan D ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Morbidity; Muscle mass; Prevalence; Sarcopenia

Indexed keywords

ACTIVIN RECEPTOR 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; GROWTH HORMONE; TESTOSTERONE; VITAMIN D;

BODY WEIGHT; DAILY LIFE ACTIVITY; DIET THERAPY; EDITORIAL; FRAIL ELDERLY; GERIATRIC PATIENT; HUMAN; MUSCLE CELL; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RESISTANCE TRAINING; SARCOPENIA;

EID: 84878123819     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-012-0089-z     Document Type: Editorial

References (43)

1. Critchley M. The neurology of old age. Lancet. 1931;217: 1331-7.
2. Shock NW. Physiologic aspects of aging. J Am Diet Assoc. 1970;56: 491-6.
3. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127: 990S-1.
4. Morley JE. Aspects of the medical history unique to older persons. JAMA. 1993;269: 677-8.
5. Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging. 2008;12: 452-6.
6. von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle. 2010;1: 1-5.
7. Morley JE, Kim MJ, Haren MT, Kevorkian R, Banks WA. Frailty and the aging male. Aging Male. 2005;8: 135-40.
8. van Kan A. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13: 708-12.
9. Blake GM, Fogelman I. An update on dual-energy x-ray absorptiometry. Semin Nucl Med. 2010;40: 62-73.
10. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49: M85-94.
11. Buchner DM, Larson EB, Wagner EH, Koepsell TD, de Lateur BJ. Evidence for a non-linear relationship between leg strength and gait speed. Age Ageing. 1996;25: 386-91.
12. Podsiadlo D, Richardson S. The timed "up & go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39: 142-8.
13. Bean JF, Kiely DK, LaRose S, Alian J, Frontera WR. Is stair climb power a clinically relevant measure of leg power impairments in at-risk older adults. Arch Phys Med Rehabil. 2007;88: 604-9.
14. Scharf G, Heineke J. Finding good biomarkers for sarcopenia. J Cachexia Sarcopenia Muscle. 2012;3: 145-8.
15. Cesari M, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, van Kan GA, et al. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle. 2012;3: 181-90.
16. Drey M, Sieber CC, Bauer JM, Uter W, Dahinden P, Fariello RG, et al. C-terminal agrin fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction. Exp Gerontol. 2012. doi: 10. 1016/j. exger. 2012. 05. 021.
17. Hettwer S, Dahinden P, Kucsera S, Farina C, Ahmed S, Fariello R, et al. Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients. Exp Gerontol. 2012. doi: 10. 1016/j. exger. 2012. 03. 002.
18. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int. 2010;21: 543-59.
19. Kostka T. Quadriceps maximal power and optimal shortening velocity in 335 men aged 23-88 years. Eur J Appl Physiol. 2005;95: 140-5.
20. Fülster S, Tacke M, Sandek S, Ebner N, Tschöpe C, Doehner W, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 2012; in press.
21. Wickham C, Cooper C, Margetts BM, Barker DJ. Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing. 1989;18: 47-51.
22. Sayer AA, Syddall HE, Martin HJ, Dennison EM, Anderson FH, Cooper C. Falls, sarcopenia, and growth in early life: findings from the Hertfordshire cohort study. Am J Epidemiol. 2006;164: 665-71.
23. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147: 755-63.
24. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and precachexia: joint document elaborated by special interest groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010;29: 154-9.
25. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50: 889-96.
26. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000;55: M221-31.
27. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39: 412-23.
28. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12: 403-9.
29. Sipilä S, Suominen H. Effects of strength and endurance training on thigh and leg muscle mass and composition in elderly women. J Appl Physiol. 1995;78: 334-40.
30. Burton LA, Sumukadas D. Optimal management of sarcopenia. Clin Interv Aging. 2010;5: 217-28.
31. Lenk K, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2010;1: 9-21.
32. Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev 2009; 3: CD002759.
33. Gielen S, Sandri M, Kozarez I, Kratzsch J, Teupser D, Thiery J, et al. Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study. Circulation. 2012;125: 2716-27.
34. Houston DK, Nicklas BJ, Ding J, Harris TB, Tylavsky FA, Newman AB, et al. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the health, aging, and body composition (Health ABC) study. Am J Clin Nutr. 2008;87: 150-5.
35. Rozentryt P, von Haehling S, Lainscak M, Nowak JU, Kalantar-Zadeh K, Polonski L, et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle. 2010;1: 35-42.
36. Scognamiglio R, Piccolotto R, Negut C, Tiengo A, Avogaro A. Oral amino acids in elderly subjects: effect on myocardial function and walking capacity. Gerontology. 2005;51: 302-8.
37. Fülster S, von Haehling S. A prospective study of the associations between 25-hydroxyvitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol. 2011;74: 138.
38. Hagerty L, Lachey JL, Kumar R, Pearsall RS, Sherman M, Seehra J. Age-related lean tissue loss is attenuated by treatment with a form of soluble activin receptor type IIB. J Cachexia Sarcopenia Muscle. 2010;1: 65-6. Abstract: 051.
39. Murphy KT, Koopman R, Naim T, Léger B, Trieu J, Ibebunjo C, Lynch GS. Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J. 2010;24: 4433-42.
40. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1: 129-33.
41. Janssen I. Influence of sarcopenia on the development of physical disability: the cardiovascular health study. J Am Geriatr Soc. 2006;54: 56-62.
42. Rolland Y, Lauwers-Cances V, Cournot M, Nourhashémi F, Reynish W, Rivière D, et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003;51: 1120-4.
43. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95: 1851-60.